Literature DB >> 8764958

Time-dependent effects of cholinergic stimulation on beta cell responsiveness.

W S Zawalich1, K C Zawalich, G G Kelley.   

Abstract

The effects of cholinergic stimulation on beta cell insulin secretory and phosphoinositide (PI) responses were determined in freshly isolated rat islets. Increasing the glucose level perifusing the islet from 5.6 to 8mM was accompanied by a modest insulin secretory response. The further addition of 10 microM carbachol increased peak first- and second-phase responses by 2.6- and 6. 8-fold, respectively. In the presence of 5.6 mM glucose, this low level (10 microM) of carbachol increased insulin release two- to three-fold, a response that was maintained for at least 60 min. In contrast to these acute stimulatory actions in the presence of glucose, chronic 3.5-h exposure of islets to 10 microM carbachol abolished beta cell insulin secretory responses to stimulation, with the combination of 8 mM glucose plus 10 microM carbachol. However, the further addition of 200 microM tolbutamide to these islets increased insulin secretory rates significantly. To establish the role of islet cell PI hydrolysis in these secretory responses, additional studies were conducted with islets whose PI pools were labeled with [3H]inositol. Acute exposure to 10 microM carbachol alone significantly increased inositol phosphate accumulation and the efflux of [3H]inositol, even in the absence of glucose. Including 10 microM carbachol during the labeling period with [3H]inositol resulted in significant impairments in subsequently measured inositol phosphate accumulation and [3H]inositol efflux responses to 8 mM glucose plus carbachol stimulation. Prior long-term exposure to 10 microM carbachol also induced heterologous desensitization: 20 mM glucose-stimulated insulin release and inositol phosphate accumulation were impaired in a parallel fashion. Chronic carbachol exposure had no deleterious effect on the usage of 8 or 20 mM glucose or on the insulin content of the islet. The acute stimulatory effects of carbachol on inositol phosphate accumulation as well as its inhibitory effect on 20 mM glucose-stimulated insulin release after prolonged exposure to the muscarinic agonist were significantly reduced by atropine. These findings demonstrate that changes in PI hydrolysis parallel those observed with insulin secretion and suggest that alterations in phospholipase C activation may account, at least in part, for the insulin secretory responses observed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8764958     DOI: 10.1007/s004240050174

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  30 in total

1.  Sustained diacylglycerol formation from inositol phospholipids in angiotensin II-stimulated vascular smooth muscle cells.

Authors:  K K Griendling; S E Rittenhouse; T A Brock; L S Ekstein; M A Gimbrone; R W Alexander
Journal:  J Biol Chem       Date:  1986-05-05       Impact factor: 5.157

Review 2.  Inositol phosphates: synthesis and degradation.

Authors:  P W Majerus; T M Connolly; V S Bansal; R C Inhorn; T S Ross; D L Lips
Journal:  J Biol Chem       Date:  1988-03-05       Impact factor: 5.157

3.  Studies of the cholinergic receptors involved in the secretion of insulin using isolated perfused rat pancreas.

Authors:  M M Loubatières-Mariani; J Chapal; R Alric; A Loubatières
Journal:  Diabetologia       Date:  1973-12       Impact factor: 10.122

4.  Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas.

Authors:  S Mojsov; G C Weir; J F Habener
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

5.  Phosphatidylinositol 4,5-bisphosphate turnover is transient while phosphatidylinositol turnover is persistent in thyrotropin-releasing hormone-stimulated rat pituitary cells.

Authors:  A Imai; M C Gershengorn
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

6.  Evidence that the epidermal growth factor receptor and non-tyrosine kinase hormone receptors stimulate phosphoinositide hydrolysis by independent pathways.

Authors:  J R Hepler; R A Jeffs; W R Huckle; H E Outlaw; S G Rhee; H S Earp; T K Harden
Journal:  Biochem J       Date:  1990-09-01       Impact factor: 3.857

7.  Protein kinase C inhibits epidermal growth factor-dependent tyrosine phosphorylation of phospholipase C gamma and activation of phosphoinositide hydrolysis.

Authors:  W R Huckle; J R Hepler; S G Rhee; T K Harden; H S Earp
Journal:  Endocrinology       Date:  1990-10       Impact factor: 4.736

8.  Effects of cholecystokinin (CCK)-4, nonsulfated CCK-8, and sulfated CCK-8 on pancreatic somatostatin, insulin, and glucagon secretion in the dog: studies in vitro.

Authors:  K Hermansen
Journal:  Endocrinology       Date:  1984-05       Impact factor: 4.736

9.  Hyperinsulinemia induces a reversible impairment in insulin receptor function leading to diabetes in the sand rat model of non-insulin-dependent diabetes mellitus.

Authors:  H Kanety; S Moshe; E Shafrir; B Lunenfeld; A Karasik
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

10.  Characteristics of desensitization of insulin secretion in fully in vitro systems.

Authors:  J L Bolaffi; L Bruno; A Heldt; G M Grodsky
Journal:  Endocrinology       Date:  1988-05       Impact factor: 4.736

View more
  3 in total

Review 1.  Atypical antipsychotics and the neural regulation of food intake and peripheral metabolism.

Authors:  Karen L Teff; Sangwon F Kim
Journal:  Physiol Behav       Date:  2011-06-12

2.  Effects of prior 5-hydroxytryptamine exposure on rat islet insulin secretory and phospholipase C responses.

Authors:  Walter S Zawalich; Gregory J Tesz; Kathleen C Zawalich
Journal:  Endocrine       Date:  2004-02       Impact factor: 3.633

3.  Prolonged Activation of the Htr2b Serotonin Receptor Impairs Glucose Stimulated Insulin Secretion and Mitochondrial Function in MIN6 Cells.

Authors:  Luis Rodrigo Cataldo; María L Mizgier; Roberto Bravo Sagua; Fabián Jaña; César Cárdenas; Paola Llanos; Dolores Busso; Pablo Olmos; José E Galgani; José L Santos; Víctor A Cortés
Journal:  PLoS One       Date:  2017-01-27       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.